Clinical outcome of patients with a vitamin K antagonist‐associated bleeding treated with prothrombin complex concentrate

Volume: 2, Issue: 1, Pages: 77 - 84
Published: Jan 1, 2018
Abstract
Essentials•Data on clinical outcome of vitamin K antagonist (VKA)‐associated bleeding is scarce.•Cohort study of patients with VKA bleeds treated with prothrombin complex concentrate (PCC).•Effective haemostasis was achieved in 68% of patients with a VKA‐associated bleeding.•Thromboembolism rates were low and mortality rates high at 30 days after PCC administration.BackgroundVitamin K antagonists (VKA) are used for the treatment of...
Paper Details
Title
Clinical outcome of patients with a vitamin K antagonist‐associated bleeding treated with prothrombin complex concentrate
Published Date
Jan 1, 2018
Journal
Volume
2
Issue
1
Pages
77 - 84
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.